The University of Chicago Header Logo

Cancer-selective targeting of the NF-?B survival pathway with GADD45ß/MKK7 inhibitors.

Cancer-selective targeting of the NF-?B survival pathway with GADD45ß/MKK7 inhibitors. Cancer Cell. 2014 10 13; 26(4):495-508.

View in: PubMed